# AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio

- Source: PR Newswire
- Published: 2026-10-18T22:10:00+00:00
- Category: Local
- Original: https://www.prnewswire.com/news-releases/abbvie-to-present-data-at-the-2026-european-society-for-medical-oncology-esmo-congress-highlighting-progress-across-its-expanding-solid-tumor-portfolio-302911997.html
- Canonical: https://groundlevelnews.com/story/abbvie-to-present-data-at-the-2026-european-society-for-medical-oncolo-b83985/

New and updated data across seven assets in lung, colorectal, ovarian, prostate and gastric cancers underscore the potential of AbbVie's oncology portfolio to address diverse patient needs through next-generation ADCs, combination approaches and precision medicine AbbVie's largest ESMO...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._